摘要
目的分析^(131)I治疗甲状腺乳头状癌转移灶的临床价值。方法随机选取48例甲状腺乳头状癌转移灶患者,对患者采取^(131)I治疗。结果48例患者临床治疗总有效率85.4%。随访至2015年12月,未出现肾功能异常情况,无严重消化道反应、脱发、喉头水肿等并发症,个别患者出现乏力、恶心呕吐、白细胞轻微降低等症状,未影响治疗。结论 ^(131)I治疗甲状腺乳头状癌转移灶效果显著,不良反应少。
Objective To analyze the clinical value of -（131） I in the treatment of metastatic thyroid papillary carcinoma. Methods 48 cases of papillary carcinoma of the thyroid gland were randomly selected,and the patients were treated with -（131） I. Results The total effective rate was 48 in 85.4% patients. Up to Dec 2015,did not appear abnormal renal function,no complications such as serious gastrointestinal reaction,alopecia,laryngeal edema,individual patients appeared fatigue,nausea and vomiting,white blood cells slightly decreased symptoms,did not affect the treatment. Conclusion -（131） I in the treatment of thyroid papillary carcinoma metastasis has significant effect,less adverse reactions.
出处
《中国卫生标准管理》
2016年第1期90-91,共2页
China Health Standard Management
